Grifols

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Grifols and buy or sell other stocks, ETFs, and their options commission-free!

About GRFS

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. 

CEO
Jose Ignacio Abia Buenache
CEOJose Ignacio Abia Buenache
Employees
23,833
Employees23,833
Headquarters
Barcelona, Catalonia
HeadquartersBarcelona, Catalonia
Founded
1909
Founded1909
Employees
23,833
Employees23,833

GRFS Key Statistics

Market cap
7.97B
Market cap7.97B
Price-Earnings ratio
15.00
Price-Earnings ratio15.00
Dividend yield
1.55%
Dividend yield1.55%
Average volume
461.56K
Average volume461.56K
High today
$9.30
High today$9.30
Low today
$9.14
Low today$9.14
Open price
$9.22
Open price$9.22
Volume
416.32K
Volume416.32K
52 Week high
$11.14
52 Week high$11.14
52 Week low
$6.19
52 Week low$6.19

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.